NEW YORK, NY / ACCESS Newswire / May 20, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=149389&wire=1&utm_campaign=19 or contact Joseph E. Levi, Esq.

Denmark's economy contracted 0.5% in the first quarter of 2025, largely due to the pharmaceutical industry.

Everything about UnitedHealth right now feels like total chaos, so I decided to explain what happened, why it matters, and what questions are worrying the investors the most. The stock is down over 50% because of everything at once: a surprise CEO exit, DOJ investigation talks, mispriced Medicare Advantage plans, and serious political pressure. Valuation is historically low, profitability metrics are still strong, and the dividend is safe.

COTY appears undervalued relative to peers, with long-term growth potential driven by digital expansion and strategic initiatives, though near-term challenges suggest caution.

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces Investigation of Vestis Corporation (VSTS) on Behalf of Investors.

CrowdStrike Holdings Inc. NASDAQ: CRWD continues to be one of the best-performing technology stocks and cybersecurity stocks. But with that performance, many investors are looking at the company's valuation.

NEW YORK--(BUSINESS WIRE)-- #M365--93% of employees visit their company intranet but spend 6 minutes a day there so it's essential content is accurate and AI-ready - SWOOP Analytics.

Home Depot's revenue climbed in the first quarter as customers spent slightly more as they tackled smaller projects.A number of U.S. companies have lowered or pulled financial guidance for investors as tariffs launched by the the Trump administration scramble world trade but on Tuesday, Home Depot stuck by earlier projections of sales growth at around 2.8%.Shares of the Atlanta company rose more than 3% before the opening bell on Tuesday.Revenue rose to $39.86 billion from $36.42 billion a year earlier, beating the $39.3 billion that analysts polled by FactSet expected.Sales at stores open at least a year, a key gauge …

Victoria's Secret adopted a shareholder rights plan on Tuesday, after Australian billionaire Brett Blundy's investment firm increased its stake in the lingerie maker.

Pfizer (PFE) has announced a new agreement to develop and market a cancer drug currently being developed by Chinese drugmaker 3SBio.

Late-stage data shows that treatment with an 80mg dose of IONS' Tryngolza achieved a 61% placebo-adjusted reduction in triglyceride levels in six months.

Three Wide Mode stocks with strong short-term upsides are: PFE, KO, DIS.

U.S. stocks traded lower this morning, with the Nasdaq Composite falling more than 100 points on Tuesday.

Cadillac's expanding all-electric vehicle lineup is attracting a notable number of new buyers to the American luxury brand, including an increase this year of Tesla owners trading in their EVs. The GM brand reports nearly 8 out of every 10 customers purchasing a Cadillac EV are new to Cadillac, with around 10% of those customers trading in a Tesla.

LA MIRADA, Calif. & SAN FRANCISCO--(BUSINESS WIRE)-- #digitalfiber--SDSU is the first research institution in the world connected with a native 800 Gbps connection to CENIC's CalREN.

NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GoHealth, Inc. ("GoHealth" or "the Company") (NASDAQ:GOCO). Investors who purchased GoHealth securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/GOCO.

NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Dentsply Sirona Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY). Investors who purchased Dentsply securities prior to May 6, 2021, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/XRAY.

NEW YORK, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atkore Inc. ("Atkore" or "the Company") (NYSE:ATKR). Investors who purchased Atkore securities prior to August 2, 2022, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/ATKR.

NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Semtech Corporation ("Semtech" or "the Company") (NASDAQ:SMTC). Investors who purchased Semtech securities prior to August 27, 2024, and continue to hold to the present, are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/SMTC.

NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of UroGen Pharma Ltd. ("UroGen" or "the Company") (NASDAQ:URGN).